Oakstone Intensive Review of Nephrology 2025

New Release! Unmatched Board Prep and Nephrology Update

The Intensive Review of Nephrology is an advanced online video course from Harvard Medical School, designed to deliver an in-depth update across all areas of nephrology. Through 70+ expert-led lectures and case discussions, you’ll gain essential, evidence-based knowledge for optimizing diagnosis, treatment, and patient outcomes.

This continuing medical education program is ideal for clinicians seeking a comprehensive review and physicians preparing for ABIM certification or recertification. Expert faculty from Harvard Medical School present practical, evidence-driven strategies for managing common and complex renal conditions. Highlights include:

Genetic testing for improved diagnosis, prognosis and therapy selection
Introduction to point-of-care ultrasound: fundamentals for optimal image acquisition and accurate interpretation
Physical exam of the dialysis access
Further expansion of the roles of SGLT2i and finerenone in diabetic and non-diabetic kidney disease
New insights in immunology and the pathogenesis of glomerulonephritis
Novel immunosuppressive agents for glomerulonephritis
And more…

Date of Original Release: October 15, 2025
Estimated Time to Complete the Activity: 50.00 hours

Learning Objectives

Upon completion of this activity, participants will be able to:

Summarize current/recommended nephrology guidelines in clinical practice
Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
Identify/integrate current therapeutic options for specific renal disorders
Review and interpret up-to-date literature relevant to clinical practice
Describe pathophysiological mechanisms as they apply to management of renal disease
Synthesize teachings to better performance on the ABIM Nephrology certification/recertification examinations
Target Audience

The target audience for the” Intensive Review of Nephrology” Course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties.

 

+ Topics:

 

Renal Physiology for the Boards – Melanie P. Hoenig, MD

Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon Bonegio, MD

Question and Answer Session – Faculty

Renal Pathology in 2025 – Part 1 – Nephritic Conditions – Helmut G. Rennke, MD

Renal Pathology in 2025 – Part 2 – Nephritic Syndrome – Astrid Weins, MD, PhD

Urine Sediment Analysis – Martina M. McGrath, MB BCh

Question and Answer Session – Faculty

Pathogenesis, Diagnosis, and Treatment of IgA Nephropathy – Gerald B. Appel, MD

Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD

Keynote – AI in Nephrology – Girish N. Nadkarni, MD, MPH, CPH

Question and Answer Session – Faculty

Treating Lupus Nephritis in 2025 – New Guidelines, New Medications, and New Challenges – Gerald B. Appel, MD

Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD

Anemia Management – Update and Best Practices – Brona M. Moloney, MBBCH, BAO, MMSc

Question and Answer Session – Faculty

Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir

Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, Bchir

Question and Answer Session – Faculty

Sodium Disorders – David B. Mount, MD

Potassium Disorders – David B. Mount, MD

Question and Answer Session – Faculty

Important New Trials in GN – David B. Mount, MD

Genetics and Kidney Disease – Friedhelm Hildebrandt, MD

Update on Polycystic Kidney Disease – Fouad T. Chebib, MD, FASN

Pediatric Nephrology – Michael J.G. Somers, MD

Genetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD

Diagnosis and Treatment of ANCA-associated Vasculitis – John L. Niles, MD

Question and Answer Session – Faculty

Why Do We Reject a Transplant? – Jamil R. Azzi, MD

Transplant Immunosuppression for the Boards – Brittany L. Schreiber, MD

Question and Answer Session – Faculty

Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD

Early Post-Transplant Management – Anil K. Chandraker, MD

Question and Answer Session – Faculty

Evaluation of the Living Donor Candidate – Kassem Safa, MD

Late Loss of the Kidney Transplant – Rania Khedher El Fekih, MD

Infections in Transplant Recipients – Barbra M. Blair, MD

Monitoring Kidney Transplant Patients – Beyond Creatinine – Jamil R. Azzi, MD

Pre-Transplant Surgical Evaluation of Recipients – Rania Khedher El Fekih, MD

Question and Answer Session – Faculty

Poisonings and Intoxications – What a Nephrologist Needs to Know – Charlotte E. Goldfine, MD

Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD

Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD

Geriatric Nephrology – Ernest I. Mandel, MD

Cardio-Renal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI

Management of Hypertension in CKD-Intensive or Standard Regimens – Richard J. Glassock, MD

Question and Answer Session – Faculty

Primary Aldosteronism – Anand Vaidya, MD, MMSc

Keynote – Climate Change, Global Inequities, and the Kidney – Valerie A. Luyckx, MBBCh, MSc, PhD

Liver and the Kidney – Andrew S. Allegretti, MD, MSc

Question and Answer Session – Faculty

Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD

Acute Kidney Injury Syndromes – Alice Sheridan, MD

ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh

Question and Answer Session – Faculty

Acute Kidney Injury in Cancer – Raad Chowdhury, MD

Paraprotein-Induced Kidney Injury – Raad Chowdhury, MD

Therapy of Focal and Segmental Glomerulosclerosis (FSGS) Lesions in 2025 – Richard J. Glassock, MD

Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh

APOL1 and Kidney Disease – Opeyemi Olabisi, MD, PhD

Question and Answer Session – Faculty

Patient Perspective – Dialysis Dosing – Moderators – J. Kevin Tucker, MD and Paul Moore; Dialysis Patients – Daphne Rhodes and Vanessa Evans

Chronic Kidney Disease – Mineral and Bone Disease – David Bushinsky, MD

Question and Answer Session – Faculty

Dialysis – A Case-Based Clinical Review and Update – J. Kevin Tucker, MD

Chronic Kidney Disease – Mineral and Bone Disease Case-Based Pearls – David Bushinsky, MD

Chronic Kidney Disease Epidemiology – Gearoid M. McMahon, MB BCh

Question and Answer Session – Faculty

Introduction to Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC

Complications of Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC

Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Shruti Gupta, MD

Question and Answer Session – Faculty

Mesoamerican Nephropathy – David J. Friedman, MD

Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD

Dialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD

Question and Answer Session – Faculty

Glomerulonephritis – Questions & Answers Session – Gerald B. Appel, MD

Must-Know Clinical Images in Nephrology – Annie Liu, DO, MPH, MS

Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, Bchir

Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, Bchir

Chronic Kidney Disease in the Community – Leveraging Resources Effectively, Lessons Learned from KDSAP – Li-Li Hsiao, MD, PhD, FACP

COVID-19 Vaccination in Immunocompromised Patients – Ann Woolley, MD

Update on Renovascular Disease – Joseph M. Garasic, MD

Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD

Immunologic Basis of Kidney Disease – Vivek Kasinath, MD

Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD

Interstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH

Ethics in Nephrology – Valerie Luyckx, MD, MB BCh

Pregnancy and Renal Disease – Jessica Tangren, MD

Transplant Cases – Board Review Practice – Melissa Y. Yeung, MD and Edgar L. Milford, MD

Transplant Board Review – Anil K. Chandraker, MD

Must-Know Board Zebras – Emily Robinson, MD, MPH

Nephrology Board Review Practice 1 – Finnian McCausland, MB BCh, MMSc, FRCPI

Nephrology Board Review Practice 2 – Gearoid M. McMahon, MB BCh